EUROIMMUNBlog Medizinische Labordiagnostika AG

  • Antibody testing reduces dengue vaccination risk
    by Dr. Rebekka Witte on May 23, 2024 at 1:39 pm

    As the COVID-19 pandemic has recently demonstrated, vaccinations are one of the most important and effective preventive measures in medicine for the protection against an infectious disease. Dengue fever is one of the most common infectious diseases worldwide, but often underestimated. Dengue fever is caused by dengue virus (DENV) which is, among others, spread to Der Beitrag Antibody testing reduces dengue vaccination risk erschien zuerst auf EUROIMMUNBlog.

  • Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
    by Dr. Johanna Scholz on April 25, 2024 at 3:01 pm

    Press release Lübeck, 25 April 2024 Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This collaboration brings together EUROIMMUN’s extensive distribution network and support infrastructure with ALPCO-GeneProof’s Der Beitrag Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings erschien zuerst auf EUROIMMUNBlog.

  • Our solutions for maximum blot efficiency!
    by Swantje Seifert on April 4, 2024 at 8:25 am

    With the introduction of the EUROMicroblots last year, we miniaturised our successful blot technology to the size of a microplate well to make processing even more efficient and to save resources. The perfect device to match: Our compact Microwell Imager. The benchtop device for image acquisition of EUROMicroblots works at a speed of one image Der Beitrag Our solutions for maximum blot efficiency! erschien zuerst auf EUROIMMUNBlog.

  • Let’s embark on a new journey together!
    by Swantje Seifert on March 13, 2024 at 7:26 am

    Get started with us as a trusted partner on the way to a simple and reliable routine for your allergy diagnostics! The (ChLIA) journey begins The use of chemiluminescence immunoassays (ChLIAs) in allergy diagnostics is not new. However, finding a suitable, reliable and simple random-access solution can sometimes be difficult. This is where our IDS-iSYS Der Beitrag Let’s embark on a new journey together! erschien zuerst auf EUROIMMUNBlog.

  • The new generation of CSF ELISAs
    by Dr. Johanna Scholz on March 5, 2024 at 8:55 pm

    CSF diagnostics means the analysis of the fluid that circulates in the brain and the bone marrow (liquor cerebrospinalis, cerebrospinal fluid). It is a valuable tool to detect acute or chronic inflammatory processes in the central nervous system (CNS). The cause of such often severe diseases of the CNS may be infections with bacteria (e.g. Der Beitrag The new generation of CSF ELISAs erschien zuerst auf EUROIMMUNBlog.

    Feed has no items.